Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.630
+0.020 (1.24%)
Oct 13, 2025, 4:00 PM EDT - Market closed
Inhibikase Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.